Effect of antioxidant therapy on cyclooxygenase-derived eicosanoid release during intestinal ischemia-reperfusion

M. Borós, L. Bako, S. Nagy

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Conflicting data have been reported on the relationship between reactive oxygen intermediates and the formation of oxygenase-derived eicosanoids. Plasma levels of prostacyclin (PGI2, measured as the stable metabolite 6-keto-PGF(1α)) and thromboxane A2 (TxA2, measured as TxB2) in the effluent blood of a canine ileal segment were determined following 1 or 2h of ischemia. The synthesis of both eicosanoids was significantly stimulated during reperfusion, but extension of the ischemic interval from 60 to 120 min was not followed by a further increase. The role of oxidants potentially involved in the process was investigated by using materials that inactivate the xanthine-oxidase-generated intermediates. Previous studies on the same in vivo animal model had demonstrated the effectiveness of antioxidant therapy in reducing the postischemic histamine release. There was no significant alteration in the amount of eicosanoids synthesized following oral allopurinol, catalase, dimethylsulfoxide, mannitol or desferrioxamine treatment. Intravenously administered allopurinol, however, significantly elevated the postischemic 6-keto-PGF(1α)/TxB2 ratio. The results suggest that these antioxidants at doses inhibitory to histamine liberation are not effective in influencing the postischemic eicosanoid release. Intravenously administered allopurinol could exert a potentially beneficial effect through a mechanism other than the blockade of xanthine oxidase.

Original languageEnglish
Pages (from-to)141-150
Number of pages10
JournalEuropean Surgical Research
Volume23
Issue number3-4
Publication statusPublished - 1991

Fingerprint

Eicosanoids
Prostaglandin-Endoperoxide Synthases
Allopurinol
Reperfusion
Ischemia
Antioxidants
Xanthine Oxidase
Histamine Release
Prostaglandins F
Epoprostenol
Oxygenases
Thromboxane A2
Deferoxamine
Mannitol
Therapeutics
Dimethyl Sulfoxide
Oxidants
Catalase
Canidae
Animal Models

Keywords

  • Antioxidant therapy
  • Ischemia-reperfusion
  • Prostacyclin
  • Thromboxane A Allopurinol

ASJC Scopus subject areas

  • Surgery

Cite this

Effect of antioxidant therapy on cyclooxygenase-derived eicosanoid release during intestinal ischemia-reperfusion. / Borós, M.; Bako, L.; Nagy, S.

In: European Surgical Research, Vol. 23, No. 3-4, 1991, p. 141-150.

Research output: Contribution to journalArticle

@article{db40162344394cce861a20832c3e4a29,
title = "Effect of antioxidant therapy on cyclooxygenase-derived eicosanoid release during intestinal ischemia-reperfusion",
abstract = "Conflicting data have been reported on the relationship between reactive oxygen intermediates and the formation of oxygenase-derived eicosanoids. Plasma levels of prostacyclin (PGI2, measured as the stable metabolite 6-keto-PGF(1α)) and thromboxane A2 (TxA2, measured as TxB2) in the effluent blood of a canine ileal segment were determined following 1 or 2h of ischemia. The synthesis of both eicosanoids was significantly stimulated during reperfusion, but extension of the ischemic interval from 60 to 120 min was not followed by a further increase. The role of oxidants potentially involved in the process was investigated by using materials that inactivate the xanthine-oxidase-generated intermediates. Previous studies on the same in vivo animal model had demonstrated the effectiveness of antioxidant therapy in reducing the postischemic histamine release. There was no significant alteration in the amount of eicosanoids synthesized following oral allopurinol, catalase, dimethylsulfoxide, mannitol or desferrioxamine treatment. Intravenously administered allopurinol, however, significantly elevated the postischemic 6-keto-PGF(1α)/TxB2 ratio. The results suggest that these antioxidants at doses inhibitory to histamine liberation are not effective in influencing the postischemic eicosanoid release. Intravenously administered allopurinol could exert a potentially beneficial effect through a mechanism other than the blockade of xanthine oxidase.",
keywords = "Antioxidant therapy, Ischemia-reperfusion, Prostacyclin, Thromboxane A Allopurinol",
author = "M. Bor{\'o}s and L. Bako and S. Nagy",
year = "1991",
language = "English",
volume = "23",
pages = "141--150",
journal = "European Surgical Research",
issn = "0014-312X",
publisher = "S. Karger AG",
number = "3-4",

}

TY - JOUR

T1 - Effect of antioxidant therapy on cyclooxygenase-derived eicosanoid release during intestinal ischemia-reperfusion

AU - Borós, M.

AU - Bako, L.

AU - Nagy, S.

PY - 1991

Y1 - 1991

N2 - Conflicting data have been reported on the relationship between reactive oxygen intermediates and the formation of oxygenase-derived eicosanoids. Plasma levels of prostacyclin (PGI2, measured as the stable metabolite 6-keto-PGF(1α)) and thromboxane A2 (TxA2, measured as TxB2) in the effluent blood of a canine ileal segment were determined following 1 or 2h of ischemia. The synthesis of both eicosanoids was significantly stimulated during reperfusion, but extension of the ischemic interval from 60 to 120 min was not followed by a further increase. The role of oxidants potentially involved in the process was investigated by using materials that inactivate the xanthine-oxidase-generated intermediates. Previous studies on the same in vivo animal model had demonstrated the effectiveness of antioxidant therapy in reducing the postischemic histamine release. There was no significant alteration in the amount of eicosanoids synthesized following oral allopurinol, catalase, dimethylsulfoxide, mannitol or desferrioxamine treatment. Intravenously administered allopurinol, however, significantly elevated the postischemic 6-keto-PGF(1α)/TxB2 ratio. The results suggest that these antioxidants at doses inhibitory to histamine liberation are not effective in influencing the postischemic eicosanoid release. Intravenously administered allopurinol could exert a potentially beneficial effect through a mechanism other than the blockade of xanthine oxidase.

AB - Conflicting data have been reported on the relationship between reactive oxygen intermediates and the formation of oxygenase-derived eicosanoids. Plasma levels of prostacyclin (PGI2, measured as the stable metabolite 6-keto-PGF(1α)) and thromboxane A2 (TxA2, measured as TxB2) in the effluent blood of a canine ileal segment were determined following 1 or 2h of ischemia. The synthesis of both eicosanoids was significantly stimulated during reperfusion, but extension of the ischemic interval from 60 to 120 min was not followed by a further increase. The role of oxidants potentially involved in the process was investigated by using materials that inactivate the xanthine-oxidase-generated intermediates. Previous studies on the same in vivo animal model had demonstrated the effectiveness of antioxidant therapy in reducing the postischemic histamine release. There was no significant alteration in the amount of eicosanoids synthesized following oral allopurinol, catalase, dimethylsulfoxide, mannitol or desferrioxamine treatment. Intravenously administered allopurinol, however, significantly elevated the postischemic 6-keto-PGF(1α)/TxB2 ratio. The results suggest that these antioxidants at doses inhibitory to histamine liberation are not effective in influencing the postischemic eicosanoid release. Intravenously administered allopurinol could exert a potentially beneficial effect through a mechanism other than the blockade of xanthine oxidase.

KW - Antioxidant therapy

KW - Ischemia-reperfusion

KW - Prostacyclin

KW - Thromboxane A Allopurinol

UR - http://www.scopus.com/inward/record.url?scp=0026000260&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026000260&partnerID=8YFLogxK

M3 - Article

VL - 23

SP - 141

EP - 150

JO - European Surgical Research

JF - European Surgical Research

SN - 0014-312X

IS - 3-4

ER -